Sodium Potassium Chloride Symporter Inhibitors

All categories
DBCAT000543Therapeutic category

Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. A DrugBank category of 7 drugs. 5 of them are approved.

Part of
Diuretics
Also known as
Bumetanide Sensitive Na K Cl Transporter Inhibitors · Bumetanide Sensitive Na-K-Cl-Transporter Inhibitors · Ceiling Diuretics, High · Diuretics, High Ceiling · Diuretics, Loop
Drugs

What you can answer from here — as of June 06, 2018

7DrugsEach linked to its full drug card
Listed above
10Drug targetsEvery drug–target pair in the class, with bond type
Sign in
1,803Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
9Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Sodium Potassium Chloride Symporter Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In